Time to positivity as prognostic tool in patients with Pseudomonas aeruginosa bloodstream infection

Journal of Infection

Volumn 67, Issue 5, 2013, Pages 416-423

  Willmann, Matthias ^a   Kuebart, Ines ^a   Vogel, Wichard ^b   Flesch, Ingo ^a   Markert, Uwe ^c   Marschal, Matthias ^a   Schröppel, Klaus ^a   Autenrieth, Ingo B ^a   Hölzl, Florian ^a   Peter, Silke ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Zollernalb Hospital   (Germany)

Author keywords

Bacteremia; Blood stream infection; Cox regression; Mortality; Prognosis; Pseudomonas aeruginosa; Risk factor; ROC analysis; Time to positivity

Indexed keywords

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; COHORT ANALYSIS; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; NONHUMAN; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTION; PSEUDOMONAS INFECTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TIME TO POSITIVITY;

BACTEREMIA; BLOOD STREAM INFECTION; COX REGRESSION; MORTALITY; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RISK FACTOR; ROC ANALYSIS; TIME TO POSITIVITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BACTEREMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84884704527     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.06.012     Document Type: Article

References (30)

1. Gould I.M., Wise R. Pseudomonas aeruginosa: clinical manifestations and management. Lancet 1985, 2(8466):1224-1227.
2. Morata L., Cobos-Trigueros N., Martinez J.A., Soriano A., Almela M., Marco F., et al. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 2012, 56(9):4833-4837.
3. Kang C.I., Kim S.H., Kim H.B., Park S.W., Choe Y.J., Oh M.D., et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003, 37(6):745-751.
4. Tumbarello M., Repetto E., Trecarichi E.M., Bernardini C., De Pascale G., Parisini A., et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. Epidemiol Infect 2011, 139(11):1740-1749.
5. Aliaga L., Mediavilla J.D., Cobo F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia. J Med Microbiol 2002, 51(7):615-619.
6. Hirsch E.B., Cottreau J.M., Chang K.T., Caeiro J.P., Johnson M.L., Tam V.H. A model to predict mortality following Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis 2012, 72(1):97-102.
7. Blot F., Schmidt E., Nitenberg G., Tancrede C., Leclercq B., Laplanche A., et al. Earlier positivity of central-venous- versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol 1998, 36(1):105-109.
8. Haimi-Cohen Y., Vellozzi E.M., Rubin L.G. Initial concentration of Staphylococcus epidermidis in simulated pediatric blood cultures correlates with time to positive results with the automated, continuously monitored BACTEC blood culture system. J Clin Microbiol 2002, 40(3):898-901.
9. Liao C.H., Lai C.C., Hsu M.S., Huang Y.T., Chu F.Y., Hsu H.S., et al. Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective cohort study. Clin Microbiol Infect 2009, 15(12):1119-1125.
10. Peralta G., Roiz M.P., Sanchez M.B., Garrido J.C., Ceballos B., Rodriguez-Lera M.J., et al. Time-to-positivity in patients with Escherichia coli bacteraemia. Clin Microbiol Infect 2007, 13(11):1077-1082.
11. Marra A.R., Edmond M.B., Forbes B.A., Wenzel R.P., Bearman G.M. Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection. JClin Microbiol 2006, 44(4):1342-1346.
12. Choi S.H., Chung J.W. Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2012, 31(11):2963-2967.
13. Palmer H.R., Palavecino E.L., Johnson J.W., Ohl C.A., Williamson J.C. Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia. Eur J Clin Microbiol Infect Dis 2013 Jul, 32(7):955-959.
14. Lai C.C., Wang C.Y., Liu W.L., Cheng A., Lee Y.C., Huang Y.T., et al. Time to blood culture positivity as a predictor of drug resistance in Acinetobacter baumannii complex bacteremia. JInfect 2011, 63(1):96-98.
15. Lai C.C., Wang C.Y., Liu W.L., Hou C.C., Huang Y.T., Hsueh P.R. Time to blood culture positivity as a predictor of methicillin resistance in Staphylococcus aureus bacteremia. J Infect 2011, 62(2):190-191.
16. Peralta G., Rodriguez-Lera M.J., Garrido J.C., Ansorena L., Roiz M.P. Time to positivity in blood cultures of adults with Streptococcus pneumoniae bacteremia. BMC Infect Dis 2006, 6:79.
17. Khatib R., Riederer K., Saeed S., Johnson L.B., Fakih M.G., Sharma M., et al. Time to positivity in Staphylococcus aureus bacteremia: possible correlation with the source and outcome of infection. Clin Infect Dis 2005, 41(5):594-598.
18. Martinez J.A., Pozo L., Almela M., Marco F., Soriano A., Lopez F., et al. Microbial and clinical determinants of time-to-positivity in patients with bacteraemia. Clin Microbiol Infect 2007, 13(7):709-716.
19. Huang L., Zhang Y.Y., Sun L.Y. Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia. Eur J Clin Microbiol Infect Dis 2013 Jul, 32(7):917-922.
20. Defrance G., Birgand G., Ruppe E., Billard M., Ruimy R., Bonnal C., et al. Time-to-positivity-based discrimination between Enterobacteriaceae, Pseudomonas aeruginosa and strictly anaerobic Gram-negative bacilli in aerobic and anaerobic blood culture vials. J Microbiol Methods 2013, 93(2):77-79.
21. Vandenbroucke J.P., von Elm E., Altman D.G., Gotzsche P.C., Mulrow C.D., Pocock S.J., et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 2007, 4(10):e297.
22. Calandra T., Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005, 33(7):1538-1548.
23. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
24. Le Gall J.R., Lemeshow S., Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270(24):2957-2963.
25. EUCAST Breakpoint tables for interpretation of MICs and zone diameters 2012.
26. Leclercq R., Canton R., Brown D.F., Giske C.G., Heisig P., Macgowan A.P., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013 Feb, 19(2):141-160.
27. EUCAST EUCAST disk diffusion method for antimicrobial susceptibility testing 2012.
28. Abbo A., Carmeli Y., Navon-Venezia S., Siegman-Igra Y., Schwaber M.J. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur J Clin Microbiol Infect Dis 2007, 26(11):793-800.
29. Lodise T.P., Patel N., Kwa A., Graves J., Furuno J.P., Graffunder E., et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 2007, 51(10):3510-3515.
30. Plorde J.J., Tenover F.C., Carlson L.G. Specimen volume versus yield in the BACTEC blood culture system. J Clin Microbiol 1985, 22(2):292-295.